CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Trends Analyst Outlook Journalist POV

63 hedge funds and large institutions have $50.2M invested in CASI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

38% less capital invested

Capital invested by funds: $80.8M → $50.2M (-$30.6M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$887K
2
+$833K
3
+$807K
4
BlackRock
BlackRock
New York
+$674K
5
Ameriprise
Ameriprise
Minnesota
+$283K

Top Sellers

1
-$256K
2
-$253K
3
-$193K
4
TSS
Two Sigma Securities
New York
-$188K
5
MC
Moors & Cabot
Massachusetts
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$28K
52
$20K
53
$9K
54
$7.62K
55
$2K
56
$1K
57
$1K
58
–
59
–
60
–
61
–
62
–
63
–
1 2
3